Esophageal Cancer Industry Forecast to Hit $2.16 Billion by 2029 With a Strong 9.3% CAGR

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Esophageal Cancer Market Size During 2025–2029?

The esophageal cancer market has shown robust expansion in recent years. Its value is anticipated to increase from $1.39 billion in 2024 to $1.51 billion by 2025, progressing at a compound annual growth rate (CAGR) of 9.0%. Historically, this growth can be ascribed to a higher incidence of cancers, enhancements in healthcare infrastructure, an escalation in alcohol consumption, a greater demand for preventive healthcare interventions, and an increased prevalence of esophageal adenocarcinoma.

The market for esophageal cancer treatments is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach “$2.16 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 9.3%. Key factors driving this growth during the forecast period include the increasing incidence of esophageal cancer, greater public awareness of health issues, advancements in healthcare infrastructure, prolonged use of tobacco and alcohol, and the rising occurrence of esophageal adenocarcinoma. Noteworthy trends expected over the forecast period encompass technological innovations in therapies, higher spending on research and development, broader adoption of precision medicine, the creation of targeted treatments, more engagement in clinical trials, and enhanced partnerships among academic bodies, drug manufacturers, and healthcare organizations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12637&type=smp

Which Drivers Are Impacting The Esophageal Cancer Market?

The growing prevalence of esophageal cancer is anticipated to fuel expansion within the esophageal cancer market. This condition refers to a malignant growth impacting the esophagus, the conduit linking the throat to the stomach. A rise in its occurrence will consequently elevate the need for diagnostic methods like endoscopy, various imaging tests, and biopsies to identify and verify the disease’s presence. For example, data from the American Cancer Society indicates that in 2023, 16,120 new deaths were attributed to esophageal cancer, with a projected increase to 16,130 by 2024. This upward trend in esophageal cancer cases is therefore predicted to stimulate the overall growth of the esophageal cancer market.

Which Key Segments Fueling The Esophageal Cancer Market?

The esophageal cancermarket covered in this report is segmented –

1) By Type: Esophageal Squamous-Cell Carcinoma; Esophageal Adenocarcinoma; Other Types

2) By Treatment Type: Chemotherapy; Targeted Therapy; Other Treatment Types

3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy

5) By End Users: Hospitals; Homecare; Specialty Centers; Other End Users

Subsegments:

1) By Esophageal Squamous-Cell Carcinoma: Localized Squamous-Cell Carcinoma; Advanced Squamous-Cell Carcinoma

2) By Esophageal Adenocarcinoma: Localized Adenocarcinoma; Advanced Adenocarcinoma

3) By Other Types: Neuroendocrine Tumors; Sarcomas; Mixed Cell Type Carcinomas

What Trends Are Expected To Drive The Esophageal Cancer Market?

A significant trend emerging in the esophageal cancer market is the increasing focus on new drug approvals. Leading companies within the esophageal cancer market are concentrating their efforts on securing approvals for new drugs to reinforce their market standing and achieve a competitive edge. An example of this is Bristol Myers Squibb, a US-based pharmaceutical company, which in May 2022, obtained U.S. Food and Drug Administration (FDA) approval for two of its offerings: Opdivo (nivolumab) (injection for intravenous use) and Opdivo plus Yervoy (ipilimumab). These therapeutic options are primarily intended for individuals diagnosed with advanced or metastatic esophageal squamous cell carcinoma (ESCC). This authorization was granted after a Phase 3 clinical trial evaluation showed improved overall survival rates among patients administered these drugs.

Which Key Market Players Are Investing In Expansion And Innovation Of Esophageal Cancer Market?

Major companies operating in the esophageal cancer market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Esophageal Cancer Market?

North America was the largest region in the esophageal cancer market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Esophageal Cancer Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12637&type=smp

Browse Through More Reports Similar to the Global Esophageal Cancer Market 2025, By The Business Research Company

Cancer Biologics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report

Cancer Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

Cancer Tumor Profiling Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795